Marino, Stram & Associates LLC Vertex Pharmaceuticals Inc Transaction History

Marino, Stram & Associates LLC

  • $445 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021
SELL
$181.39 - $202.99 $185,561 - $207,658
-1,023 Closed
0 $0
Q2 2021

Jul 22, 2021
BUY
$187.49 - $221.1 $191,802 - $226,185
1,023 New
1,023 $206,000
Q2 2019

Jul 19, 2019
SELL
$164.61 - $190.37 $3,786 - $4,378
-23 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $3,351 - $3,909
23 New
23 $4,000

Others Institutions Holding VRTX

# of Institutions
1,717
Shares Held
226M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Marino, Stram & Associates LLC Portfolio

Follow Marino, Stram & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marino, Stram & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email